These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. [Clinical research at the European LeukemiaNet]. Saussele S; Adam K; Hochhaus A; Béné MC; Büchner T; Burnett A; Finazzi G; Fonatsch C; Gluckman E; Gökbuget N; Grimwade DJ; Haferlach T; Hallek M; Hasford J; Hoelzer D; Ljungman P; Niederwieser D; Serve H; Simonsson B; de Witte TJ; Hehlmann R; Dtsch Med Wochenschr; 2006 Oct; 131(43):2423-6. PubMed ID: 17054061 [No Abstract] [Full Text] [Related]
7. Standardization of autoimmune diagnostics in Germany: activities of the German group in the European Autoimmune Standardization Initiative. Sack U; Conrad K; Csernok E; Frank I; Haass M; Krieger T; Seyfarth M; Schlosser U; Schmidt RE; Witte T Ann N Y Acad Sci; 2007 Aug; 1109():31-6. PubMed ID: 17785287 [TBL] [Abstract][Full Text] [Related]
8. The incidence of secondary leukemias. Leone G; Mele L; Pulsoni A; Equitani F; Pagano L Haematologica; 1999 Oct; 84(10):937-45. PubMed ID: 10509043 [TBL] [Abstract][Full Text] [Related]
9. [The German competence network inflammatory bowel disease (KNCED) -- network research leads to the identification of the cause of disease and to the improvement in patient care]. Sina C; Schreiber S; Hoffmann JC; Rogler G; Schölmerich J; Zeitz M; Fölsch UR Med Klin (Munich); 2006 Feb; 101(2):161-5. PubMed ID: 16501914 [TBL] [Abstract][Full Text] [Related]
10. [Modern approach to diagnosis and therapy in childhood leukemias]. Hasanbegović E Med Arh; 2004; 58(1):59-60. PubMed ID: 15017909 [TBL] [Abstract][Full Text] [Related]
12. [Study on the transformation from myelodysplastic syndromes into acute leukemias]. Shi J; Shao Z; Liu H; Li K; Song L; Zhang Y; Zheng Y; Chen G; Chu Y; He H; Zhao M; He G; Feng B; Hao Y; Yang T; Yang C Zhonghua Xue Ye Xue Za Zhi; 2001 Jul; 22(7):351-4. PubMed ID: 11877096 [TBL] [Abstract][Full Text] [Related]
13. Current status of vaccination therapy for leukemias. Reichardt VL; Brossart P Curr Hematol Rep; 2005 Jan; 4(1):73-6. PubMed ID: 15610663 [TBL] [Abstract][Full Text] [Related]
14. Molecular genetics of human leukemias: new insights into therapy. Gilliland DG Semin Hematol; 2002 Oct; 39(4 Suppl 3):6-11. PubMed ID: 12447846 [TBL] [Abstract][Full Text] [Related]
15. A web-based central diagnostic data repository. Müller TH; Adelhard K Stud Health Technol Inform; 2002; 90():246-50. PubMed ID: 15460696 [TBL] [Abstract][Full Text] [Related]
16. Telomerase activity and telomere length in acute and chronic leukemia, pre- and post-ex vivo culture. Engelhardt M; Mackenzie K; Drullinsky P; Silver RT; Moore MA Cancer Res; 2000 Feb; 60(3):610-7. PubMed ID: 10676644 [TBL] [Abstract][Full Text] [Related]
17. [Integrated Center for Research and Treatment of Vertigo, Balance and Ocular Motor Disorders]. Brandt T; Zwergal A; Jahn K; Strupp M Nervenarzt; 2009 Aug; 80(8):875-86. PubMed ID: 19662450 [TBL] [Abstract][Full Text] [Related]
18. The NCI All Ireland Cancer Conference. Johnston PG; Daly PA; Liu E Oncologist; 1999; 4(4):275-277. PubMed ID: 10545862 [TBL] [Abstract][Full Text] [Related]
19. Prognostic markers for myeloid neoplasms: a comparative review of the literature and goals for future investigation. Juopperi TA; Bienzle D; Bernreuter DC; Vernau W; Thrall MA; McManus PM Vet Pathol; 2011 Jan; 48(1):182-97. PubMed ID: 21139142 [TBL] [Abstract][Full Text] [Related]
20. Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders. Cortes J; Giles F; O'Brien S; Thomas D; Albitar M; Rios MB; Talpaz M; Garcia-Manero G; Faderl S; Letvak L; Salvado A; Kantarjian H Cancer; 2003 Jun; 97(11):2760-6. PubMed ID: 12767088 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]